TP53 and neoplasm: miR‐221 cause proliferation of tumour by targeting cyclin‐dependent kinase inhibitor 1B (CDKN1B (p27)), upregulated modulator of apoptosis (PUMA (p53)), and PTEN genes [88, 89, 90, 91].